Z3A-11178-40551
2 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 641 / MO
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-03
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Headache, Muscle or body aches, DiarrheaAdult check-in
- 2021-04-05
- 2021-04-07
- 2021-04-09
- 2021-04-10
- 2021-04-17
- 2021-04-26
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-07-03
- 2021-10-02
-
2021-11-10
Dose 2 — Pfizer-BioNTech
-
2021-11-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
-
2021-11-24
Survey response — day 14, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-12-01
Survey response — day 21, dose 2MedDRA: Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: UTIMedDRA releases: 2024-11 · check-in free text available
-
2021-12-01
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2021-12-02
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-12-10
- 2021-12-17
- 2021-12-22
- 2022-02-09
- 2022-05-11
- 2022-11-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-01 | Successful 2021-12-02 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 10 — day 14, dose 2
Symptoms: Sore throat
Release 10 — day 21, dose 2
Symptoms: UTI
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release